Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2020
2020 World Conference on Lung Cancer
Conference Program for the 2020 World Conference on Lung Cancer
Presentation Date(s):- January 28 - 31, 2021
- Total Presentations: 1597
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
FP13 - Immunotherapy (Phase II/III Trials)
- Type: Posters (Featured)
- Track: Immunotherapy (Phase II/III Trials)
- Presentations: 4
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
FP13.02 - Pembrolizumab + Pemetrexed-Platinum vs Pemetrexed-Platinum for Metastatic NSCLC: 4-Year Follow-up From KEYNOTE-189
00:00 - 00:00 | Presenter: Jhanelle Elaine Gray
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P76 - Targeted Therapy - Clinically Focused - EGFR
- Type: Posters
- Track: Targeted Therapy - Clinically Focused
- Presentations: 98
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P76.57 - Resistance Mechanisms to Osimertinib Upon it’s Line of Therapy in Patients with EGFR+ NSCLC and Beyond
00:00 - 00:00 | Presenter: Vered Fuchs
- Abstract
Loading...
-
+
P84 - Targeted Therapy - Clinically Focused - ALK
- Type: Posters
- Track: Targeted Therapy - Clinically Focused
- Presentations: 23
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P84.03 - GLASS: Global Lorlatinib for ALK(+) and ROS1(+) Retrospective Study: Real World Data of 123 NSCLC Patients
00:00 - 00:00 | Presenter: Nir Peled
- Abstract
Loading... -
+
P84.10 - The Impact of 3rd-Line ALK Inhibitors in ALK Positive NSCLC in Real-World Data
00:00 - 00:00 | Presenter: Mor Moskovitz
- Abstract
Loading...
-
+
P87 - Targeted Therapy - Clinically Focused - RET
- Type: Posters
- Track: Targeted Therapy - Clinically Focused
- Presentations: 5
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P87.01 - Higher Dose Alectinib for Advanced RET+ NSCLC: Results from the RET+ Cohort of the Blood First Assay Screening Trial (BFAST)
00:00 - 00:00 | Presenter: Nir Peled
- Abstract
Loading...
-
+
IS09 - Industry Symposium Sponsored by Pfizer Oncology: Expert Question Time: ALK+ NSCLC
- Type: Industry Symposium
- Track:
- Presentations: 7
- Coordinates: 1/29/2021, 13:00 - 14:00, Industry Symposia Auditorium (via Industry Hub)
-
+
IS09.02 - The Future of ALK+ NSCLC
13:45 - 13:45 | Presenter: Nir Peled
- Abstract
No abstract available for this presentation
